semaglutide weight loss shelby charter township Review: 'The Drug Helped Me Lose 30 Pounds At Age 52' MEDICAL WEIGHT LOSS CLINIC -

The ASMBS 2022 guidelines acknowledge that anti-obesity medications (AOMs) represent a valuable tool in the comprehensive management of post-bariatric weight regain, though evidence remains limited compared to primary obesity treatment

Given the widespread use of these drugs, potential safety concerns deserve attention

Important considerations include: Potential interactions with hormonal contraceptives (particularly with tirzepatide and exenatide) Pregnancy planning (GLP-1 medications require discontinuation before conceptiontypically 2 months for semaglutide and 1 month for tirzepatide) Management of gastrointestinal side effects that might overlap with endometriosis symptoms Some hormonal therapies for endometriosis can affect weight, and addressing metabolic health may be a separate but important consideration

Firkins SA, Yates J, Shukla N, et al